Page last updated: 2024-11-05

thiotepa and Hypertrophy

thiotepa has been researched along with Hypertrophy in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ZINCA, V1
STRIMBEANU, I1

Other Studies

1 other study available for thiotepa and Hypertrophy

ArticleYear
MORPHOLOGICAL ASPECTS IN EXFOLIATIVE VAGINAL CYTOLOGY FOLLOWING ANTICANCEROUS CHEMOTHERAPY.
    Neoplasma, 1963, Volume: 10

    Topics: Antineoplastic Agents; Aziridines; Breast Neoplasms; Cell Nucleus; Coloring Agents; Cyclophosphamide

1963